IVF on Nasdaq

INVO Fertility, Inc.

American surgical and medical instruments and apparatus company. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with ENCISION INC, Beyond Air, Inc. or Plus Therapeutics, or pick any stock.

  • TickerIVF on Nasdaq1
  • IndustrySurgical & Medical Instruments & Apparatus1
  • HeadquartersSarasota, Florida1
  • Incorporated inNV2
  • Business address5582 Broadcast Court, Sarasota, Fl 342402
  • Filer categoryNon-accelerated filer, Smaller reporting company2
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

Form 10-K certain material events and developments that have taken place through the date of filing of this Form 10-K with the SEC.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

-105.8%Operating margin4
-340.9%Net margin4
4.3%Revenue growth, 20254
-322.8%Return on equity4
0.10×Debt to equity4
-$7.1MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue0¢$30.6K
  • Selling, general and admin98¢$7.7M
  • Income tax2¢$150.4K

Out of $6.8M in revenue.4 The company lost money this year.

Financial statements

Revenue567894$6.8M in 2025+362% since 2019
0$2.0M$4.0M$6.0M$8.0M2019: $1.5M$1.5M20192020: $1.0M$1.0M2020−30%2021: $4.2M$4.2M2021+301%2022: $822.2K$822.2K2022−80%2023: $3.0M$3.0M2023+267%2024: $6.6M$6.6M2024+117%2025: $6.8M$6.8M2025+4%
Gross profit567$490.7K in 2022−63% since 2019
0$2.0M$4.0M$6.0M2019: $1.3M$1.3M20192020: $948.5K$948.5K2020−29%2021: $4.0M$4.0M2021+323%2022: $490.7K$490.7K2022−88%
Operating income567894-$7.2M in 2025+305% since 2019
-$15.0M-$10.0M-$5.0M02019: -$1.8M-$1.8M20192020: -$5.5M-$5.5M2020+208%2021: -$5.2M-$5.2M2021−5%2022: -$10.6M-$10.6M2022+104%2023: -$6.8M-$6.8M2023−36%2024: -$6.6M-$6.6M2024−2%2025: -$7.2M-$7.2M2025+9%
Net income567894-$23.3M in 2025+976% since 2019
-$30.0M-$20.0M-$10.0M02019: -$2.2M-$2.2M20192020: -$8.3M-$8.3M2020+285%2021: -$6.7M-$6.7M2021−20%2022: -$10.9M-$10.9M2022+64%2023: -$8.0M-$8.0M2023−26%2024: -$9.3M-$9.3M2024+15%2025: -$23.3M-$23.3M2025+152%
Fiscal year2019202020212022202320242025
Revenue$1.5M5$1.0M6$4.2M7$822.2K8$3.0M9$6.6M9$6.8M4
Cost of revenue$139.7K5$88.8K6$145.1K7$331.5K7$2.0M9$3.7M9$30.6K4
Gross profit$1.3M5$948.5K6$4.0M7$490.7K7
Research and development$05$398.4K6$216.4K7$544.0K8$165.9K9$4.9K4
Selling, general and admin$3.1M5$6.1M6$9.0M7$10.0M8$7.5M9$8.1M4$7.7M4
Operating expenses$9.2M7$11.4M8$9.8M9$14.7M9$14.1M4
Operating income-$1.8M5-$5.5M6-$5.2M7-$10.6M8-$6.8M9-$6.6M4-$7.2M4
Interest$387.6K5$2.8M6$1.3M7$59.4K8$925.9K9$1.1M9
Income before tax-$6.7M7-$10.9M8-$8.0M9-$7.6M4-$5.5M4
Income tax$4335$366$4.8K7$2.9K8$27.8K9$140.2K4-$150.4K4
Net income-$2.2M5-$8.3M6-$6.7M7-$10.9M8-$8.0M9-$9.3M4-$23.3M4
Earnings per share-$0.455-$1.526-$0.637-$17.978-$67.379-$3,782.654-$214.644
Earnings per share (diluted)-$0.455-$1.526-$0.637-$17.978-$67.379-$3,782.654-$214.644
Shares (weighted, basic)10.6M shares7606.1K shares8119.3K shares92.5K shares4117.1K shares4
Shares (weighted, diluted)10.6M shares7606.1K shares8119.3K shares92.5K shares4117.1K shares4

Compare INVO Fertility, Inc. with another company

Leadership

Who has led INVO Fertility, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Kathleen T. Karloff2017–2019
  2. Steve Shum2019–now

Chair

  1. Kathleen T. Karloff2017–2018

President

  1. Claude Ranoux2017
  2. Kathleen T. Karloff2019

Chief financial officer

  1. Robert Joseph Bowdring Jr.2017
  2. Debra Robbins Hoopes2019
  3. Andrea Goren2021–2026
  4. Terah Renee Krigsvold2026–now
20202025
Board members and other officers (12)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Chief Operating Officer and VP of Business DevelopmentMichael Campbell named Jan 11, 2023 to Apr 6, 202330

Former names

  • NAYA Biosciences, Inc.Jun 5, 2024 to Apr 14, 20252
  • INVO Bioscience, Inc.Jan 8, 2009 to Oct 15, 20242
  • EMY'S SALSA AJI DISTRIBUTION COMPANY, INC.Nov 13, 2007 to Jan 5, 20092

Timeline

  1. Oct 18, 2019New chief executive Steve Shum becomes CEO12
  2. Jul 3, 2017New chief executive Kathleen T. Karloff becomes CEO13

Filings

303 filings to the SEC since October 2021: 13 annual reports, 16 quarterly reports, 127 major events, 36 insider forms, 18 large holders, 4 private raises, 89 other. The latest 20:

  1. Oct 9, 2026SCHEDULE 13G/A EDGAR
  2. Aug 28, 2026S-8 EDGAR
  3. Aug 28, 20268-K EDGAR
  4. Aug 17, 20268-K EDGAR
  5. Aug 14, 202610-Q EDGAR
  6. Aug 14, 2026SCHEDULE 13G/A EDGAR
  7. Aug 7, 2026424B3 EDGAR
  8. Aug 7, 2026SCHEDULE 13G EDGAR
  9. Aug 4, 2026EFFECT EDGAR
  10. Jul 24, 2026S-1 EDGAR
  11. Jul 24, 20268-K EDGAR
  12. Jun 25, 20268-K EDGAR
  13. Jun 23, 2026DEF 14A EDGAR
  14. Jun 22, 20268-K EDGAR
  15. Jun 22, 202610-Q EDGAR
  16. Jun 16, 20268-K EDGAR
  17. Jun 12, 2026PRE 14A EDGAR
  18. Jun 12, 202610-K/A EDGAR
  19. Jun 2, 20268-K EDGAR
  20. Jun 2, 202610-K EDGAR

The 303 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

12 open-market trades by officers, directors and large owners since October 2021: 11 buys and 1 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Dec 3, 2025Szot Matthew KDirectorSale4$1.52$6Form 4
Jun 1, 2022Shum SteveChief Executive OfficerBuy58,885$0.95$55.9KForm 4
Jun 1, 2022Ryan BarbaraDirectorBuy10,526$0.95$10.0KForm 4
Jun 1, 2022DAVIS TRENT DDirectorBuy11,184$0.95$10.6KForm 4
Jun 1, 2022Szot Matthew KDirectorBuy14,474$0.95$13.8KForm 4
Jun 1, 2022Segal JeffreyDirectorBuy9,211$0.95$8.8KForm 4
Jun 1, 2022Campbell Michael Jos.Chief Operating OfficerBuy10,526$0.95$10.0KForm 4
Jun 1, 2022Goren AndreaChief Financial OfficerBuy52,632$0.95$50.0KForm 4
Jun 1, 2022Messina RebeccaDirectorBuy9,868$0.95$9.4KForm 4
Jun 1, 2022Doody KevinMedical DirectorBuy177,306$0.95$168.4KForm 4
Oct 5, 2021Goren AndreaChief Financial OfficerBuy30,674$3.26$100.0KForm 4
Oct 5, 2021Shum SteveChief Executive OfficerBuy30,674$3.26$100.0KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Mar 23, 2023Raised $3 million in a private offering of securities Form D: 1 investor so far Form D
  2. Feb 3, 2023Raised $500,000 in a private offering of securities Form D: 2 investors so far Form D
  3. Jan 4, 2023Raised $275,000 in a private offering of securities Form D: $3.5 million offered in all Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Scientech Research LLC32,338$61.4K0.0%New
StoneX Group Inc.15,702$29.8K0.0%New
Susquehanna International Group, Llp11,463$21.8K0.0%New
Tower Research Capital LLC (TRC)8,155$15.5K0.0%New
Virtu Financial LLC63,174$1200.0%New
SBI Securities Co., Ltd.53$1010.0%+50
Caitong International Asset Management Co., Ltd38$720.0%New
Integrated Wealth Concepts LLC8$150.0%New
Danske Bank A/s1$20.0%New

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38